Nasal Spray VIRALEZE™ For Respiratory and Cold Viruses, Including New Strains

VIRALEZE™, developed by Starpharma, is available for purchase online at www.viraleze.co / www.viraleze.co.uk  and through certain retail partners. For further information, visit the official websites. VIRALEZE™, developed by Starpharma, is available for purchase online atwww.viraleze.co/ www.viraleze.co.uk  and through certain retail partners. For further information, visit the official websites. Starpharma is also currently completing a post-market study of VIRALEZE™ at St Peter's...

VIRALEZE™, developed by Starpharma, is available for purchase online at www.viraleze.co / www.viraleze.co.uk  and through certain retail partners. For further information, visit the official websites.

Starpharma is also currently completing a post-market study of VIRALEZE™ at St Peter's Hospital, UK, where its ability to reduce viral load in COVID-19-positive patients is being evaluated. For more information, see https://www.ashfordstpeters.nhs.uk/viraleze-nasal-spray-trial.

Stephen Winchester, Consultant Virologist at St Peter's Hospital, said: "The VIRALEZE™ trial is being conducted at a time where there are increasing levels and new variants of COVID-19 emerging in the community, as well as other respiratory and cold viruses increasing as we enter the winter months. The VIRALEZE™ trial will assist in understanding the product's role in shortening illness duration and limiting spread of the virus."

View original content:https://www.prnewswire.co.uk/news-releases/nasal-spray-viraleze-for-respiratory-and-cold-viruses-including-new-strains-301931356.html